Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -97.64M
March 31, 2026 -133.22M
December 31, 2025 -153.49M
September 30, 2025 -164.64M
June 30, 2025 -154.97M
March 31, 2025 -138.43M
December 31, 2024 -126.87M
September 30, 2024 -115.38M
June 30, 2024 -113.58M
March 31, 2024 -104.32M
December 31, 2023 -102.24M
September 30, 2023 -104.48M
June 30, 2023 -108.43M
March 31, 2023 -110.98M
December 31, 2022 -109.16M
September 30, 2022 -109.37M
June 30, 2022 -113.75M
Date Value
March 31, 2022 -113.28M
December 31, 2021 -110.82M
September 30, 2021 -112.89M
June 30, 2021 -111.50M
March 31, 2021 -116.63M
December 31, 2020 -128.48M
September 30, 2020 -136.93M
June 30, 2020 -130.37M
March 31, 2020 -121.50M
December 31, 2019 -105.15M
September 30, 2019 -89.89M
June 30, 2019 -88.17M
March 31, 2019 -83.72M
December 31, 2018 -75.66M
September 30, 2018 -62.01M
June 30, 2018 -41.77M
March 31, 2018 -29.95M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Xencor, Inc. -163.32M
MeiraGTx Holdings Plc 78.93M
Insmed, Inc. -875.31M
Ironwood Pharmaceuticals, Inc. 129.87M
Viking Therapeutics, Inc. -534.80M